Journal article icon

Journal article

Barriers to routine G6PD testing prior to treatment with primaquine.

Abstract:

Background

Primaquine is essential for the radical cure of vivax malaria, however its broad application is hindered by the risk of drug-induced haemolysis in individuals with glucose-6-phosphate-dehydrogenase (G6PD) deficiency. Rapid diagnostic tests capable of diagnosing G6PD deficiency are now available, but these are not used widely.

Methods

A series of qualitative interviews were conducted with policy makers and healthcare providers in four vivax-endemic count...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1186/s12936-017-1981-y

Authors


Expand authors...
ustralian Government Department of Foreign Affairs and Trade More from this funder
Bill and Melinda Gates Foundation More from this funder
US President’s Malaria Initiative More from this funder
Publisher:
BioMed Central Publisher's website
Journal:
Malaria Journal Journal website
Volume:
16
Issue:
1
Pages:
329
Publication date:
2017-08-01
Acceptance date:
2017-08-07
DOI:
EISSN:
1475-2875
Pmid:
28797255
Source identifiers:
724233
Language:
English
Keywords:
Pubs id:
pubs:724233
UUID:
uuid:688c5ba2-7a05-4127-8a77-fd9d4dd44166
Local pid:
pubs:724233
Deposit date:
2017-08-25

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP